UAE announces ministers for state ministers for happiness, tolerance, youth

Bengaluru, Jun 28: The Karnataka government on Saturday issued an order, directing private hospitals not to deny treatment to patients with coronavirus and COVID-19 like symptoms.

"Non-compliance of this order will attract punishment under sections of Disaster Management Act 2005," an order read.

Meanwhile, people coming from Maharashtra will be placed in seven-day institutional quarantine followed by seven-day home quarantine in Karnataka, the state government said.

People coming from other states will need to undergo 14-day home quarantine.

Belagavi, Feb 25: Left Parties will launch countrywide door-to-door campaign from March 1 to 23 against Citizenship (Amendment) Act (CAA), National Population Register (NPR), National Register of Citizens (NRC), Communist Party of India (M) General Secretary Sitaram Yechury said on Tuesday.

Addressing a press conference here, he said that CPI (M) and other Left parties were participating in the awareness programme that will conclude on March 23, on the martyrdom day of Bhagat Singh, Chandrashekar and Rajguru.

"Till now 13 states have expressed their opposition for NRC and will not implement it, which means more than fifty per cent of country will not have it," he added.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.